Current Reports (8-K / 6-K)

Darren Entwistle retires as CEO and Board member effective June 30, 2026, after 26 years of leadership; he will serve as CEO Emeritus and advisor to Victor Dodig until April 2027.

Victor Dodig, former CIBC CEO (2014–2025) and TELUS Board member since 2022, becomes CEO on July 1, 2026, following a comprehensive succession process.

Shareholders will vote on increasing the RSU Plan share reserve from 49,000,000 to 62,600,000 shares — a 27.8% expansion supporting future equity-based compensation.

Deloitte LLP is proposed for re-appointment as independent auditor for the ensuing year, having served in that capacity since 2002 and most recently re-appointed at the May 9, 2025 AGM.

An advisory 'say on pay' vote is scheduled to approve TELUS’s executive compensation approach, consistent with annual practice since 2011.

Form 6-K filed with Items listed as N/A.

Exhibit 99.1 provided as encoded PDF content (tm2610149d2_ex99-1.pdf).

No explicit financial results, executive changes, or material events identifiable in filing.

Filing date confirmed as 2026-04-02.

Azul S.A. AGM scheduled for April 30, 2026, at 4:00 p.m. exclusively online via Ten Meetings platform.

Agenda includes review of FY 2025 financial statements ended December 31, 2025, with independent auditor Grant Thornton opinion.

Company recorded net income of BRL 124,857,418.70 for FY 2025.

Matters to resolve: managers' accounts approval, 2025 results allocation, and 2026 managers' annual global compensation.

Remote voting ballot deadline April 26, 2026; registration and proxy submission by April 28, 2026.

Fiscal Council term ends at AGM; shareholders with 2%+ shares may request installation.

Dr. Peter Slavin notified the company of his resignation from the Board of Directors on April 1, 2026.

The resignation will be effective on the date of the company's next annual meeting of stockholders in 2026.

Dr. Slavin will continue to serve as a director until the annual meeting.

The resignation results from Dr. Slavin's transition to a new role on the West Coast of the United States.

The resignation is not due to any disagreement with the company on operations, policies, or procedures.

Dr. Slavin served on the Board of Directors for more than nine years.

The company completed its IPO of 20,000,000 units at $10.00 each, generating gross proceeds of $200 million.

Simultaneously, it sold 235,000 private placement units to KPET Ultra Paceline Unit Holdings LLC for $2.35 million, subject to a 30-day lock-up.

Three new independent directors were appointed to the board and audit committee, each purchasing 40,000 Class B shares.

Approximately $200 million of net proceeds, including deferred underwriting fees, were deposited into a trust account, restricted until a business combination or liquidation.

The company entered into multiple definitive agreements, including underwriting, warrant, and registration rights agreements, in connection with the offering.

Entered Sales Agreement with Roquette Frères on March 28, 2026 for pea protein supply through 2027 with minimum purchases totaling ~$23.5 million.

Company must pay liquidated damages if minimum annual quantities not purchased, subject to partial rollover.

Required to procure $1.0 million standby letter of credit to secure payment obligations.

Board approved 2026 Employment Inducement Equity Incentive Plan effective March 30, 2026 without stockholder approval.

Inducement Plan reserves 10,000,000 shares of common stock for new hires per Nasdaq Rule 5635(c)(4).

No incentive stock options permitted under Inducement Plan; terms similar to 2018 Equity Incentive Plan.

Net income of $2.7 million ($0.18/share) in 2025 reversed a $7.6 million loss in 2024, driven by a $7.3 million gain on discontinued operations.

Cash and cash equivalents decreased to $1.3 million as of December 31, 2025, from $3.2 million in the prior year.

The Company stated it will require additional capital and anticipates cash resources will be exhausted in the second quarter of 2026 without new financing.

Administrative expenses were reduced to $2.3 million in 2025 from $3.6 million in 2024, reflecting cost reduction efforts.

Completed the exit from Velardeña properties and sold non-core Mexican subsidiaries to reduce liabilities and overhead.

The Hart-Scott-Rodino antitrust waiting period for the Coterra-Devon merger expired on April 1, 2026, removing a major regulatory hurdle.

The merger closing is expected in the second quarter of 2026, subject to remaining customary closing conditions.

Devon's registration statement for the merger was declared effective on March 26, 2026, and definitive proxy materials were mailed to stockholders starting March 30, 2026.

The merger structure involves Merger Sub merging into Coterra, with Coterra surviving as a wholly-owned subsidiary of Devon.

Investors are directed to review detailed merger information in the SEC-filed registration statement and joint proxy statement/prospectus.

Company entered LCF Forbearance Agreement on March 27, 2026, with lenders and Natixis as agent.

Forbearance covers specified defaults under July 16, 2021 Letter of Credit Agreement.

Agreement terminates September 15, 2026, unless extended; post-termination may require cash collateralization.

Contains consents, covenants, and termination rights consistent with March 17, 2026 Restructuring Support Agreement.

Indicates ongoing restructuring efforts to recapitalize Company indebtedness.

Mr. Allan J. Camaisa intends to allow his director term to expire at the 2026 annual stockholder meeting.

Camaisa's decision resulted from no disagreement with Company operations, policies or practices.

Board reduced size from six to five directors effective on 2026 annual stockholder meeting date.

Board eliminated Class III director vacancy following Camaisa's notice.

Scott Leftwich appointed to Audit Committee effective April 1, 2026.

Tom Peck resigned as Executive Vice President, Chief Information and Digital Officer.

Resignation effective April 10, 2026.

Notified Company on March 27, 2026.

Resigned to accept opportunity in different industry.

No disagreements with Company on operations, policies, or practices.

The Annual and Special Meeting of Security Holders is scheduled for June 23, 2026.

The record date for notice, voting, and beneficial ownership determination is April 30, 2026.

Only common shares are entitled to receive notice of and vote at the meeting.

The meeting will be conducted using Notice-and-Access for both registered shareholders and beneficial holders.

The reporting issuer is not sending proxy-related materials directly to Non-Objecting Beneficial Owners.

The issuer is not paying for delivery to Objecting Beneficial Owners.

Q1 2026 operating and financial results to be released after market close on April 29, 2026.

Conference call and webcast scheduled for April 30, 2026 at 9:00 a.m. ET with registration and dial-in options provided.

Webcast archive available until July 30, 2026; audio replay until May 30, 2026.

Annual meeting of shareholders set for May 5, 2026 at 11:00 a.m. ET in virtual format via live audio webcast.

Meeting details and proxy materials accessible on company website, SEDAR+, and EDGAR.

Entered Amended and Restated Business Loan Agreement with East West Bank on March 27, 2026.

Maximum borrowing $18,000,000 subject to borrowing base limitations.

Maturity extended to April 17, 2027.

Collateralized by all assets of FGI Industries; guaranteed by Company, subsidiaries, and Liang Chou Chen (49.91% voting control of Foremost Groups Ltd).

Financial covenants require monthly YTD EBITDA of up to $1.6M consolidated and $1.4M unconsolidated.

Interest at Prime Rate plus 0-1.5% margin (min 4.500%); customary events of default.

Entered Amended and Restated Business Loan Agreement with East West Bank on March 27, 2026.

Maximum borrowing $18,000,000 subject to borrowing base limitations.

Maturity extended to April 17, 2027.

Collateralized by all assets of FGI Industries; guaranteed by Company, subsidiaries, and Liang Chou Chen (49.91% voting control of Foremost Groups Ltd).

Financial covenants require monthly YTD EBITDA of up to $1.6M consolidated and $1.4M unconsolidated.

Interest at Prime Rate plus 0-1.5% margin (min 4.500%); customary events of default.

Summit issued 1,351,351 shares of common stock to Tall Oak Midstream Holdings, an affiliate of Tailwater Capital, for $42 million in cash at $31.08 per share.

The transaction increases Tailwater Capital's beneficial ownership in Summit from approximately 35% to approximately 39% of outstanding equity.

Net proceeds are intended to reduce borrowings under the company's asset-based lending credit facility and fund organic growth capital projects.

The shares are subject to a 6-month lock-up period and were issued in a private placement exempt from SEC registration.

The transaction was unanimously approved by the Audit Committee, which is comprised solely of independent and disinterested directors.

The company will file a registration statement within 90 days to allow for resale of the shares under Rule 415.

Entered $10M revolving credit facility on March 31, 2026, with Wells Fargo as lender.

Tigo Energy MergeCo, Inc., wholly-owned subsidiary, guarantees obligations.

Borrowings limited to Borrowing Base based on accounts receivable and inventory.

Interest at SOFR plus 1.75%-2.00% margin based on excess availability.

Matures March 31, 2029; requires minimum monthly Liquidity covenant.

No loans outstanding under facility as of April 2, 2026 filing.

Starbucks completed its joint venture with Boyu Capital, finalizing the transaction announced in November 2025.

Boyu Capital funds acquired a 60% interest in Starbucks China retail operations, with Starbucks retaining 40%.

Starbucks continues to own and license the global brand and intellectual property to the joint venture.

The joint venture oversees approximately 8,000 company-operated coffeehouses in China, transitioning to a licensed model.

The partnership aims to accelerate disciplined expansion in China, with a long-term aspiration to grow to 20,000 locations.

Annual General Meeting set for June 25, 2026.

Record date for notice and voting is April 30, 2026.

Common shares entitled to notice and vote, CUSIP 88831L202.

Proxy materials sent via notice-and-access to both registered holders and beneficial owners.

Issuer not sending materials directly to NOBO or paying for OBO delivery.

No stratification of materials.

Net asset value declined $0.79 per share to $4.25 as of December 31, 2025 — a 15.65% quarterly drop — signaling material pressure on portfolio valuation and capital preservation.

Net decrease in net assets from operations was $9.4 million ($0.65 per share) for Q4 FY2025, driven by $9.5 million in net realized and unrealized losses — the largest quarterly decline in at least five quarters.

Board initiated formal review of strategic alternatives led by a Special Committee of Independent Directors with no timetable; no assurance of transaction or strategy change.

Company suspended the quarterly dividend for the period ended March 31, 2026, citing disciplined capital allocation and RIC tax status considerations.

Refinanced $65.0 million of maturing 4.875% Notes with unsecured floating-rate debt (SOFR + 5.50%) maturing July 1, 2029, provided by ICAP, an affiliate of its investment adviser.

Weighted average yield on debt investments fell to 10.56% as of December 31, 2025, down from 10.87% in Q3 FY2025, reflecting portfolio repricing or composition shifts.

Annual General Meeting scheduled for June 25, 2026 — sets timeline for shareholder governance actions including director elections and auditor ratification.

Record date for notice and voting is April 30, 2026 — determines eligibility to receive proxy materials and vote at the meeting.

Notice-and-access delivery method used for both registered holders and beneficial owners — indicates cost-efficient, electronic-first proxy distribution compliant with SEC rules.

Issuer is not sending proxy materials directly to NOBOs or paying for OBO delivery — reflects standard practice where intermediaries handle distribution to beneficial owners.

The annual and special meeting is scheduled for May 7, 2026, at Brookfield Place in New York, with a record date of March 10, 2026.

Shareholders will vote on six proposals: receiving financial statements, electing 12 directors, appointing Deloitte LLP as auditor, and advisory resolutions on executive compensation, a new management share option plan, and amendments to the escrowed stock plan.

The proxy filing deadline is May 5, 2026, at 5:00 p.m. New York time, with voting available via internet, telephone, mail, or email.

Meeting materials are available electronically via notice-and-access, with paper copies available upon request by April 21, 2026, to vote in advance.

The company reported record 2025 results including $112 billion in capital raised, $66 billion deployed, fee-bearing capital of $603 billion, fee-related earnings of $3.0 billion, and distributable earnings of $2.7 billion.

Entered amended Participation Agreement, Lease, and Guaranty on April 1, 2026, renewing five-year term for HQ at 650 West Peachtree Street NW.

Aggregate lease financing of approximately $498.7 million with BAL as sole counterparty.

Monthly rent at Term SOFR plus margin; triple-net lease covering all maintenance, taxes, insurance.

Lease now treated as finance lease for reporting, versus prior operating lease.

NSRC end-of-term options: extend five years with consent, purchase Building, or sell to third party.

Norfolk Southern unconditionally guarantees all NSRC obligations.

Chief Development Officer Eric J. Daniels will resign effective April 17, 2026, to pursue another opportunity.

The resignation did not result from any disagreement regarding the company's operations, policies, or practices.

Kiora has initiated a search for Daniels' successor.

The company states it remains focused on advancing its pipeline of treatments for retinal disease and maintaining momentum across its development programs.

The ABACUS-2 Phase 2 clinical trial (KIO-301) received approval to enroll remaining patients in the 50µg dose cohort and clearance to initiate the 100µg dose cohort.

All planned safety review checkpoints have been cleared in the KLARITY Phase 2 clinical trial (KIO-104), with patient enrollment ongoing.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

PSOC will issue $500 million aggregate principal amount of 5.000% senior notes maturing December 15, 2035 — a material new long-term debt obligation.

The notes are issued by PSOC and fully guaranteed by Public Storage, reinforcing consolidated credit support for the offering.

Notes were priced at 99.182% of par, bearing 5.000% annual interest, payable semi-annually starting June 15, 2026 — establishing fixed-rate funding cost.

Net proceeds will be used to repay amounts under PSOC’s revolving credit facility and for general corporate purposes, including acquisitions, development, and mortgage loans for self-storage facilities.

The offering closes April 6, 2026, subject to customary conditions, and is backed by a shelf registration statement filed December 2, 2024.

Issued $85.0 million aggregate principal subordinated notes due April 2, 2036, qualifying as Tier 2 capital.

Fixed rate of 6.50% through March 31, 2031, then floating at three-month SOFR + 300 bps.

Proceeds to redeem $66.93 million existing subordinated notes, support b1BANK capital, growth, and general corporate purposes.

Notes are unsecured, subordinated to senior debt, redeemable after fifth anniversary at company option.

Sold in private placement exempt under Section 4(a)(2) and Rule 506(b) of Securities Act.

Dan Whalen resigned from Harmonic’s Board of Directors effective March 31, 2026.

Resignation due to potential conflicts from new role at another company.

No disagreement with Harmonic on operations, policies, or practices.

Served on Board since 2024, previously 2021-2023, and on Audit and Compensation Committees.

Company thanked him for years of service and contributions.

Total revenues increased $2.5 million (8.8%) to $30.7 million for the year ended December 31, 2025 — reflects continued same-store growth and new asset contributions.

Same-store revenues rose 4.6% and same-store NOI increased 8.6%, while same-store occupancy declined 1.0 percentage points to 90.3% — indicates pricing power offsetting modest occupancy softness.

Net loss attributable to common stockholders decreased $10.7 million (22.7%) to $36.6 million — driven by lower acquisition expenses and improved operating leverage.

Four Canadian joint venture self-storage properties commenced operations in 2025, averaging 41% occupancy as of December 31, 2025 — early-stage lease-up with future growth potential.

Board approved $10.00 estimated per share NAV as of September 30, 2025 — unchanged from prior estimate and used for share redemption and distribution calculations.

Daily distribution rate of $0.001698 per share was declared for Q2 2026 (April–June), consistent with Q1 — signals stable income policy amid ongoing development investment.

The Company proposes to reorganize by moving its parent company domicile from Ireland to the United States (Texas).

The redomestication is expected to be completed in the third quarter of 2026, subject to shareholder and court approvals.

Strategic rationale includes simplifying corporate structure, reducing compliance costs, and broadening the potential lender base.

The proposal requires approval by the Company's shareholders and sanction by the High Court of Ireland.

Weatherford filed a preliminary proxy statement with the SEC on April 2, 2026, regarding the proposed transaction.

Ryan Elwart, Group President, tendered resignation on March 30, 2026.

Resignation effective April 27, 2026.

Departure to pursue other opportunities.

Potential leadership transition in key executive role.

Intrepid Potash-New Mexico, LLC sold the Intrepid South Ranch to HydroSource Logistics, LLC for $70.0 million in cash, including an $8.0 million deposit received in December 2025 — proceeds represent acceleration of decades of future cash flow.

The Ranch Assets include ~21,793 acres of fee land, ~27,858 acres of federal grazing leases, associated water rights, and other assets — constituting the majority of the company’s oilfield solutions segment.

The Credit Agreement was amended to extend its maturity date from its prior term to March 30, 2031, enhancing near- and medium-term debt maturity profile.

BMO Bank N.A. replaced Bank of Montreal as administrative agent and letter of credit issuer under the Credit Agreement, effective March 30, 2026.

The transaction supports Intrepid’s strategic focus on core potash and Trio® production, with CEO stating the Ranch was a noncore asset whose sale improves unit economics and financial flexibility.

A twenty-five-for-one forward stock split was effected, automatically subdividing each outstanding share into 25 shares.

Authorized common stock increased proportionally from 1,000,000,000 shares to 25,000,000,000 shares.

The amendment became effective at 4:01 p.m. Eastern Time on April 2, 2026.

Trading on a split-adjusted basis is expected to commence at market open on Monday, April 6, 2026.

The par value of common stock remains eight-tenths of a penny ($.008) per share.

Alcon's 2026 AGM scheduled for April 30, 2026 in Lausanne, fourth in-person since independence.

Board proposes electing R. Scott Herren, former Cisco CFO, as new independent director.

Proposed gross dividend of CHF 0.28 per share, ex-dividend May 5/6, 2026, payable around May 7.

Re-election of Chair F. Michael Ball and all 10 current directors for one-year terms.

Board compensation max CHF 4.275M for 2026-2027; Executive Committee CHF 47.1M for 2027.

Entered four Private Placement Agreements on January 26, March 5, March 19, and March 28, 2026 with four individual investors.

Issued aggregate 274,000 shares representing approximately 18% of shares outstanding as of December 31, 2025.

January 26 deal: 69,000 shares for US$246,330 at 90% of 5-day average closing price.

March deals at 85% of prior day closing price: 75,000 shares for US$267,750; 70,000 for US$275,800; 60,000 for US$246,000.

Shares unregistered under Securities Act, issued in cash installments with 6-month transfer restrictions.

Exhibits 10.1 and 10.2 detail agreements with standard terms on use of proceeds for operations, shareholder rights, and breach penalties.

Priced $75 million aggregate principal of 7.375% Senior Notes due 2032 at 100.985% plus accrued interest.

Additional Notes reopen existing series originally issued April 2, 2024; $450 million Notes currently outstanding.

Expected closing April 14, 2026, subject to customary conditions.

Net proceeds for general corporate purposes, including capital expenditures and M&A.

Interest payable semi-annually on April 2 and October 2; mature April 2, 2032.

Application for listing on Luxembourg Stock Exchange Euro MTF market.

Annual General Meeting scheduled for May 7, 2026 at 8:00 a.m. Mountain time via virtual LUMI platform.

11 directors nominated for election, including CEO Bevin Wirzba; 10 independent if elected.

KPMG LLP appointed auditor since October 1, 2024; billed C$3.94M in 2025 vs C$1.79M in 2024.

Non-binding advisory vote on executive compensation approach.

Record date March 9, 2026; proxies due by 8:00 a.m. MT on May 5, 2026.

Meeting to present 2025 audited financial statements.